Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank goodness...it's about time news out
The earnings release will be issued to the public pre-market on Monday, March 28, 2011.
NUIN presented yesterday at the Rodman conference & with earnings due out soon some interest is not a surprise.
NUIN volume & price showing strength today ...no new news out yet(?)
Pappy, nice volume today. Added some more at 2.93 to 2.95.
All Chinese r/merger stock are under selling pressure it seems but I believe nuin & wkbt below $3 are absolute steals.
The current product growth assures excellant growth will continue & with no debt,little A/R,high margins,accelerating revenue & earnings trends,cash flow &cash on hand strong,small float,p/e ratios less than 10% of expected growthrate,pps close to their growing B.V.,strong insider ownership.
I see a couple of 20 baggers developing for a better day.
I have a solid position in both stocks & will now await future earnings results to prove me right as I can wait as long as the reaper doesn't come after this 73 year old body.LOL
Finally got my 3/4 of my position at 3. Seems like a big seller out there. It is insane to sell at this level.
No I am averaged in around $2.95 & like you have noticed the recent weakness in spite the good 2010 results I expect.
As the current weakness in all China stocks continues going into earnings im holding a 60% cash position that will allow me to pick & choose from among the better posted results.
The pps for hfgb wkbt uta all expected to report excellant results seem to be holding back as well.
I don't believe the shorts can hold stocks down in this space much longer & I fully expect the one's with trusted audited 2010 results that give the best 1st qtr results will move up strong after reporting 1st Q results.
If my thoughts are correct we have a bit more time to decide where to put unused dollars.
I believe nuin's 1st Q results will be among the better one's reported due to increasing supply to meet demand.
Pappy, I am waiting around $3. Then i will be fully invested on NUIN. Are you adding at this level?
Functional health drinks production started in the 4th qtr are starting to reach more distribution points.
Alcoholic beverages started trial production in Q1 2011 these high margined products will be adding increasing revenue as 2011 unfolds.
Next month we will get a glimps into the early acceptance of these newer products when 2010 audited results are released.
I expect that nuin will be announcing that they are applying for a exchange listing sometime this year in order to reach out for institutional sponsership. imo
Nutrastar Appoints Two Additional Members to its Board of Directors
Last update: 1/28/2011 7:00:00 AM
New Independent Majority Enhances Corporate Governance
HARBIN, China, Jan. 28, 2011 /PRNewswire via COMTEX/ -- Nutrastar International Inc. (NUIN), a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, announced today that it has appointed Joshua Kurtzig, an experienced finance professional, and Robert Tick, Nutrastar's CFO, to its Board of Directors. With the new appointments, the board is now comprised of seven members, four of whom are independent.
Ms. Lianyun Han, Chief Executive Officer of Nutrastar, commented, "We're excited to have Joshua and Robert join the board of directors. Joshua's experience in financial management combined with strategic and operational development will be important in helping Nutrastar enhance its corporate governance and shareholder value. His experience as well as Robert's financial expertise and insights are valuable additions to our board and should provide additional confidence to our shareholders and the investment community as a whole."
Joshua Kurtzig is a Managing Director at ARC China Holdings Ltd., where he is responsible for portfolio management, deal sourcing, and overseeing the establishment of regional RMB funds.Before joining ARC China, Mr. Kurtzig was a director at DAC Management from 2008 to 2010, an Asia-focused alternative investment manager. Mr. Kurtzig also has prior financial experience at Stonebridge International, PricewaterhouseCoopers, and the International Monetary Fund. He holds a B.A. degree from University of Virginia, a M.Sc. from the London School of Economics, and an M.B.A. from NYU's Stern School of Business. Mr. Kurtzig speaks English, French, Mandarin Chinese and Russian.
Added some at 3.21 today. Hope 3.2 holds.
New Yorkers are gladly shelling out $800 an ounce for these dried dead bodies -- and the sexual prowess they promise.
It's a stiff price to pay for a fungus-encrusted silkworm.
But New Yorkers are gladly shelling out $800 an ounce for these dried dead bodies -- and the sexual prowess they promise.
The vile virility remedy known as "Himalayan Viagra" works a little differently from the blue pill. There's no immediate reaction, but sprinkle them on your corn flakes every morning and users swear it'll make your bedsprings bounce.
The wonder drug -- called "yarsagumba" or "dong chong xia cao" -- can also be brewed into an anti-impotence tea.
The insects come from the highlands of Nepal, where they are attacked by a beige fungus, cordyceps sinensis, that kills and entombs them.
Read more: http://www.nypost.com/p/news/local/arousing_success_for_love_bug_p4CC6laeuVGjIQ4Q7xdPTK#ixzz1BSFrIXTU
This will be fiscal yearend 2010 report which should be reported in about 60 days.
I am projecting revenue of $24mil with eps of $0.83 based on 16.5mil shares outstanding.
Does anyone know when is earning coming out and what eps and revenue do we expect?
Pappy, I just wanted to clarify my last post.
I have a "double up" on this one and am holding tight.
Just frustrating how a few bad apples, which all markets have, are being used as 'evidence' that all these stocks are bad.
I'm also very up on CCME and WKBT. CKGT I'm so LT on that I am dug in for all or none! LTUS....don't know.....if it climbs a bit more I may recycle the money into these puppies instead.
GLTY and all. I know I rarely post but just wanted to state that I am not a basher.
I hope that selected Chinese stocks will regain favor over the next 12 months.
I like how the growth & technicals of nuin are setting up & have set a pps target of $8.30 by early 2012. jmo
Pappy: How high do u think it will go that is fair value to u?
$3.52 unchanged with 18,655 shares traded.
All shares were traded at the ask.
I have been buying the dips but the dips are getting fewer & farther between.
Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC
Last update: 1/6/2011 8:00:00 AM
HARBIN, China, Jan. 6, 2011 /PRNewswire via COMTEX/ -- Nutrastar International Inc. (NUIN), a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, today announced that the Company will be participating in the upcoming Cowen and Company 9th Annual Consumer Conference being held at the Westin New York at Times Square (270 West 43rd Street) in New York City on January 10 - 11th, 2011. Mr. Robert Tick, Chief Financial Officer, is scheduled to present on Tuesday, January 11th at 11:30AM EST with a breakout session from 11:55 AM - 12:20PM EST.
Hopefully it will get noticed over time.
Between CNBC and companies like ENHD, these small companies are a hard sell right now.
NUIN opened its 1st specialty store close to corporate headquarters & in a neighborhood that allows NUIN to cator to middle-to-upper class consumers.
More specialty stores are expected to be opened at a later time so lets see how this test store goes as they try to increase exposer to middle & upper class consumers.
A management team with a solid plan if you ask me.
Now that annual capacity has been increased from 55 tons to 72 tons as scheduled the roll-out of health drinks can spread to a wider consumer area in 2011.
And with capacity set to expand to 100 tons by yearend 2011 production will be almost double from early 2010 limits of 55 tons.
All the newer products are of the higher margin variety making net earnings increases very strong for the remainder of 2010 & all of 2011 & beyond.
With a low float & shares outstanding eps should accelerate at a very nice pace & the p/e ratio should begin to expand in recognition of this & the very real possibilty of a major exchange listing for this very fine company with a great product that the consumer should continue to buy on a regular basis.
As this growth acceleration continues I will be increasing my position in this amigo with such a fine balance sheet to go with a product in high demand.
In 12 months a lot can change. True this space is sporting p/e ratios below 5.
But if the sequential growth nuin has had this year continues & I see little reason to think it won't I like the chances of a p/e of "ten" in 12 months.
Even ccme which has had good sequential growth got very close to a current p/e of 10 recently.
True it has given back a large portion of those gains but "if" sequential growth continues there it will regain its highs once more.
When a stock in this space doubles in a short period like ccme did one should at least sell their trading shares expecting some retracement.
As far as sequential eps continuing I have much more faith in nuin or even wkbt than I do in ccme because of share dilution in ccme that so far has been avoided by both nuin & wkbt.
In fact I sold my core shares in ccme along with my trading shares because I don't believe sequential eps growth can be expected to continue.
I do give stocks like ccme & hfgb a lot of credit for the eps growth this year in spite the large increase in share count.
However both are still adding sharecount hfgb to continue the strong revenue growth in 2011&12.
ccme on the other hand will have a large increase in share count because management is "over" rewarding itself.
They need to reward all shareholder by giving a dividend & "actually" buyback shares on the cheap to help furnish shares promised to management.
Just this old farts opinion once more.
Pappy, I guess you and me both know that it's almost completely unrealistic that this stock will have a PE of 10 within 12 months. Unfortunately. People are trusting these chinese small caps less and less instead of more and more. A lot has to change before this can become reality. Heck not even CCME can hold itself above a PE of 6 or 7. And they are the most solid company out there and trading on the big nasdaq. Not that NUIN isn't interesting here at these levels no doubt about that.
Sequential growth is excellant "even" ahead of their health drink roll-out in the 4th qtr.
Dec09 revenue $3.783M net income $1.999M
Mar10 revenue $4.768M net income $2.721M
Jun10 revenue $5.458M net income $3.416M
Sep10 revenue $6.462M net income $4.066M
Current runrate is $1.00 & with 9 months fully diluted eps of $0.58 they are on pace to have eps of $0.83+ in 2010.
As you can see from the above as revenue is increasing net income is increasing at a even faster pace due to continuous increases in margins.
This company already has one of the best margins I have ever seen & has been able to raise the price of their products a sure sign that demand far outstrips supply.
Current ratio is improving very rapidly & they have no long term debt "anymore"& a small account receivable with plenty of cash & cashflow to support future growth.
This stock is one of my 5 amigos for 2011 along with UTA HFGB
WKBT CKGT.
Notice all the amigos have a small float with margins expected to increase faster than revenue gains going forward.
And all have strong cashflow to support future growth.
All but ckgt currently have plenty of cash on hand for immediate growth needs.
ckgt has depleted its current cash buying patents & manufactoring abilty & thus the current low valuation is somewhat warranted.
As for nuin one of the most solid looking micro-cap stocks I have seen in over 50 years of investing it deserves a p/e ratio much higher than it currently has in spite of being Chinese.
I am setting a 12 month target of $8.30 on nuin a very conservative 10x expected 2010 eps & if China stocks regain respect in the investment arena I would think a p/e of at least 15 is highly deserved for this well managed little guy.
p.s. Remember to do your own DD as the above is just one old farts opinion & I make a misteke or two along the way.lol
Henry Ngan a director on 11/26/2010 purchased 5k shares @$2.98-$3.00 his total holdings 45k shares.
As I just bought a starter position the week before his purchase @$2.95 this makes me feel more confident increasing my position knowing that the roll-out is probably meeting with some success.
I have been buying a starter position today as I continue my dd on this fine young company with increasing margins,cash,cashflow along with steady double digit revenue growth that should thanks to the roll-out of their energy drinks in 2010 & expand to wine & other continued roll-outs in 2011 have 2010 eps of $0.80 with 2011 eps of $1.00+.
I realize these eps numbers are higher than the make good numbers of $9M in 2010 & $11M in 2011 but I like the chances of them beating those make good numbers.
Remember I am still doing dd & could possibly take a bigger position when finished although I see the float is rather small.
One of first buyers.
Going back aways I committed to buying stock in whatever company Gary picked as his first client(s).
I did so based on his straightforward honesty and his commitment to only take on a company that he felt would do right by investors.
I have not posted much here but neither have I sold a share.
This looks to be gelling nicely now and should be fun to watch heading into 2011.
NUIN ....
The Company has a much better website now ...
www.nutrastarintl.com
Also, they have a new and very informative Investor Presentation ...
http://content.stockpr.com/nutrastarintl/media/a593c538ec80cbc3633d2e2c8a80f154.pdf
Both worth taking a look at, IMO.
newelong
NUIN ...
If you add back the one-time charge for "Beneficial conversion feature of convertible preferred stock" Of $1.7MM in Q2 to net income of $10.2MM for the nine months you get $11.9MM or $.83 EPS based on 14.4MM FDS. Nutrastar should earn close to $1.00 per share for the year.
Also, when you eliminate the $8.9MM "acquisition payable" liability (per 10-22-10 "termination agreement"), the Company has a tangible net worth of about $45.7MM or a book value of $3.17 per share.
Just my opinion, but NUIN looks like a deal at the current price.
newelong
10Q - EPS from Q2 0.12 to Q3 0.25
http://finance.yahoo.com/news/Nutrastar-Announces-Third-prnews-449594733.html?x=0&.v=1
Nutrastar International Inc. Appoints Three Independent Board Members and Establishes the Audit, Compensation and Governance and Nominating Committees
Press Release Source: Nutrastar International Inc. On Wednesday October 6, 2010, 8:00 am EDT
HARBIN, China, Oct. 6 /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTC Bulletin Board: NUIN "Nutrastar" or the "Company"), a leading nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris") and other specialty food products in the People's Republic of China ("China"), today announced the appointment of three independent board members and the establishment of the Audit Committee, Compensation Committee and Governance and Nominating Committee. At the same time, the following directors resigned due to personal reasons: Ms. Nana Jiang, Mr. John Jing Zhang, and Mr. Xi Zhu.
The new independent directors are: Mr. Henry Ngan, chair of the Audit Committee, Ms. Virginia P'an, chair of the Compensation Committee, and Mr. JianBing Zhong, chair of the Governance and Nominating Committee.
Mr. Ngan has served as the CFO of Hong Kong Highpower Technology, Inc. since February 2009. Prior to joining the company, Mr. Ngan had served as Vice President and Senior Equity Analyst at Brean Murray, Carret & Co. in New York City from July 2008, an Equity Research Analyst at Buckingham Research Group in New York from June 2004 to January 2008 and at Robotti & Company from October 2002 until June 2004. During his tenure, Mr. Ngan accumulated a significant amount of experience in accounting, auditing, consulting and valuation analysis. Mr. Ngan received a bachelor's degree in Accounting from the University at Albany, State University of New York, and his MBA in finance, and information and communication systems from Fordham University. He is a Certified Public Accountant licensed in the state of New York.
Ms. P'an is currently the CEO of the TransCapital Group LLC and Yumi EcoSolutions, Inc. She is a seasoned global executive, successful entrepreneur and financier and a recognized international business expert. Innovator and authority on China and the Pacific Rim., Mr. P'an advises senior executives and board of directors on strategic investments, business strategy, operations and funding. Prior to founding the current companies, and its predecessor companies, she was the first female Vice President at American Express Bank and was the architect of the national debit card banking system for Taiwan. Before her current positions, Ms. P'an also served as Managing Partner for KCSA Worldwide and Managing Director of Adam Friedman Associates, two prominent financial communications and investor relations firms based in New York City. She is currently an active member of the Board of AIESEC US and the Advisory Board of the Babson Graduate School of Business which is internationally ranked #1 for entrepreneurship. Ms. P'an is the recipient of the prestigious "Leading Women Entrepreneur of the World," "Business Innovator" and "International Women of Influence" Awards and is fluent in Mandarin and other Chinese dialects.
Mr. Zhong has been with Leichi Investment Limited Company ("Leichi") since July 2007 and is principally responsible for managing the company's legal affairs including the performance of business due diligence and market research, joint project arrangement, private equity financing, corporate strategy planning and business consulting Over the years, he has participated in many joint projects covering various industries from environmental protection, new materials, new energy and modern agriculture provided to consumer and wholesales franchises. Prior to working with Leichi, Mr. Zhong was at the Fujian Yinsen Group and was responsible for undertaking the company's legal affairs. Mr. Zhong graduated from the South-Central University for Nationalities with a bachelor's degree in law.
"We are delighted to welcome Mr. Ngan, Ms. P'an and Mr. Zhong to our Board of Directors. Each of them is highly esteemed in their field and bring to Nutrastar a wealth of knowledge in their particular area of expertise," commented Ms. Lianyun Han, President and Chief Executive Officer of Nutrastar. "We believe the addition of these board members will help us establish a solid corporate governance policy in an effort to increase our transparency, particularly to the US investment community. We look forward to their beneficial contributions and to making continued strides toward uplisting to a national exchange in the future."
Re: Nuin for free now
You are missing a few things, but it is really cheap.
1. The company just restructured in order to eliminate the 8.8m due to the founder. They now have the same structure as net ease, baidu and many other chinese companies. I don't think anyone really understands that the liability just disappeared. Why did she do this - she owns most of the company anyway.
2. Production is ramping up. They had capacity of 45 tons @ 12/31/09, they are @ 55 tons now, and will be at 72 tons by Year end.
3.They have plenty of room to continue to expand without acquiring a new facility.
4. they have been successful in increasing the amount of product they sell via the retail channel - which is very high margin - they did Approx 24k packages in 6/30/09 and did 71k in 6/30/10. Most of the production still goes to the pharma companies at a much lower cost - this is because the retail product has to look really good, the pharma companies don't care what it looks like due to the fact that they use it to make TCM products . The $ revenue mix is now 50/50 retail to pharma.
5. they are on the cusp of introducing drinks made with the Golden Grass. Prelim marketing efforts have gone well. The margins here are also really high.
6. The company has a proprietary way of growing their product, making them the largest and cheapest in their niche.
7. the new CFO is very responsive and helpful in understanding the company, they presented at Rodman in Sept and will be doing a road show soon. So the IR has improved.
It is really cheap, no matter how you look at it - normalized earning for the Q ended 6/30 were $.185 using all shares, they have made more money each Q. 4x last Q earnings of .185 is $.74. the share price is 2.50 and the cash is $1.76 per share ( cash minus all liabilities). So the price is cash per share plus 1x earning assuming no additional growth (- and you can see the that the company is growing and will have added another 40% in capacity by YE)
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_N/threadview?m=tm&bn=73307&tid=44&mid=45&tof=1&rt=2&frt=2&off=1
One more note about the plant.
They apparently have obtained their plant, which was formerly a prison the the government decided to shut down and did not want. There are 10 buildings, and three are currently in use.
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_N/threadview?m=tm&bn=73307&tid=44&mid=46&tof=1&rt=2&frt=2&off=1
Re: Note 5
I was told by IR that the energy drink has already been introduced and is selling in select markets in China.
newelong
dymacfo ...
You have to look at Note 17 in the 10-Q and you`ll see a reconciliation of Net Income which includes a $1.7MM non-cash charge in connection with the Convertible Preferred Stock.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7416585-1158-159160&type=sect&dcn=0001204459-10-001931
They didn`t spell it out in their press release, but I was told by IR that they would make it clearer next time.
Hope this helps.
Phil
Gary-read your earlier report then recent mention again so reviewed their 2Q report and can't figure out how they come up with 12 cent EPS. Based upon $3.5M net and 14M+ in diluted shares this would be 24 cents not 12 cents. Also YTD calcs to 43 cents so what's up with this? Can't imagine they would understate EPS but need some help on this one. Thx.
NUIN back on the OTC.BB again.
They also had what I'm told was a solid presentation at the Rodman conference by the CFO, Robert Tick. I spoke with Robert a month ago and was very impressed with him.
Nutrastar International Inc.(NUIN) Announces Record Second Quarter 2010 Results
HARBIN, China, Aug. 16 /PRNewswire-Asia/ -- Nutrastar International Inc. (OTC Bulletin Board: NUIN; "Nutrastar" or the "Company"), a leading nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris") and other specialty food products, today announced financial results for their threeFinancial Highlights for the Three Months Ended June 30, 2010: -- Revenues increase 63.4%; -- Gross margin increases 19.1% to 83.7% -- EPS reaches $0.12
Three Months Ended June 30, 2010
Revenues reached $5.46 million, an increase of approximately $2.12 million, or 63.4% from the same period in 2009. The increase was mainly attributable to the increase in sales of the company's core product, Chinese Golden Grass, as well as an increase in selling prices for their packaged Chinese Golden Grass products.
Gross profit was $4.57 million, an increase of approximately $2.41 million, or 112.0% as compared to the same period in 2009. Gross margin was 83.7%, an increase of 19.1% from 64.6% during the same period in 2009. The increase in gross margin was mainly due to continued product mix shift towards Chinese Golden Grass and increased sales of their higher margin small package Chinese Golden Grass products.
Operating income was approximately $3.79 million, an increase of $2.07 million, or up 120.3% from the comparable period of 2009. Operating margin was 69.4% for the second quarter 2010, an increase of 17.9% from 51.5% during the comparable 2009 period.
Net income was $3.42 million, an increase of $1.92 million, or 127.7% from the same period of 2009. Basic and diluted earnings per share for both quarters ended June 30, 2010 and 2009 was $0.12.
Six Months Ended June 30, 2010
Revenues were $10.23 million, an increase of 28.1% from approximately $7.98 million recorded for the same six month period in 2009. The increase was primarily as a result of an increase in sales of their Chinese Golden Grass, as well as an increase in selling prices for their packaged Chinese Golden Grass products.
Gross profit was recorded as $8.28 million, an increase of 64.2% from approximately $5.04 million during the same period in 2009. Gross margin was 81.0% for the six months ended June 30, 2010, an increase of 17.8% from 63.2% during the same period in 2009. As mentioned above, the increase was a result of continued product mix shift towards Chinese Golden Grass and the increased sales of their higher margin products.
Operating income was approximately $6.90 million, up 64.6% from $4.19 million recorded in the same six month period of 2009. Operating margin was 67.5% for the first six months of 2010, an increase of 15.0% from 52.5% recorded in the same six month period of 2009.
Net income was $6.14 million, up 67.2% from $3.67 million recorded in the first six months of 2009. Earnings per basic share was $0.31 and per diluted share was $0.30 as compared to $0.29 for the comparable 2009 period on a basic and diluted basis.
As of June 30, 2010, the Company had cash and cash equivalents in the amount of $32.26 million and total liabilities in the amount of $11.92 million.
Ms. Lianyun Han, President and Chief Executive Officer of Nutrastar commented, "Nutrastar's performance in the second quarter was exceptional. We saw heightened consumer demand for our Golden Grass products, especially our high margin, small packaged products. This significant increase in sales suggests that consumer knowledge of the medicinal benefits of Chinese Golden Grass is gaining traction and the nutraceutical market in China is growing at a healthy rate. On a quarterly basis, revenues increased by roughly 63.4% and EPS reached $0.12, outstanding growth given the current volatile economic environment."
Ms. Han continued, "Since the second quarter ended, we announced a few important measures that will prepare the company for significant expansion and growth in the time ahead. We plan to expand our manufacturing capabilities by over 30%, increasing our production capacity to 72 tons by the end of 2010. In addition to expanding our production capacity, we are also continuously seeking to further our geographical footprint and diversify our Golden Grass product pipeline. We announced in July 2010 the signing of a product purchase agreement with Century Brighton Holdings, which will further expand our customer base and penetration into the lucrative Hong Kong market. We also announced the patent application of our Golden Grass wine and oral liquids which we anticipate will be in trial production in Q1 2011. It's expected that with our increased production capabilities, continued efforts on the R&D side, as well as further expansion of distribution network, Nutrastar will show consistent growth on both the revenue side and product side going forward."
For more information regarding Nutrastar's financial performance during the second quarter of 2010, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission on August 16, 2010.
About Nutrastar International Inc.
Nutrastar International Inc. is a China based nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris"), organic and specialty food products in China. The Company's primary product is dry engineered Chinese Golden Grass, which is one of the most highly regarded herbal nutrients in Chinese culture. The Company believes it is the largest manufacturer of engineered Chinese Golden Grass in China, ranked by volume, according to China Market Monitoring Center (CMMC), accounting for 19% market share in China. The Company is headquartered in Harbin, capital of Heilongjiang province, with 302 employees, 21 in R&D, and 132 in sales and marketing. The products of Nutrastar are sold throughout China via a distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com or e-mail: ir@nutrastarintl.com.
and six months ended June 30, 2010.
FDA CalendarHow To Use The FDA Calendar To InvestKey Tips On Using The FDA CalendarArticles
FDA News and ApprovalsMost PopularLatest NewsBreaking NewsSubscriber Only ContentUser Submitted ArticlesContribute an ArticleArticles ArchiveAbout UsBlogResearchFAQ & Support
FAQHelp Desk
Commercial and financial markets bullish on traditional Chinese medicine PDF | Print | E-mail
Written by Rob Goldman
Tuesday, 10 August 2010 03:17
2
http://biomedreports.com/articles/most-popular/50148-traditional-chinese-medicine-taking-root-in-markets.html
diggs
digg
Goldman Small Cap Research initiated coverage of Nutrastar International Inc. (OTC:BB:NUIN), a pure play on the fast-growing nutraceutical market and the Chinese domestic market, with a 19% market share. In doing so, the analyst team may have stumbled onto an undiscovered gem.
Nutrastar is the leader in the production and distribution of “Chinese Golden Grass”, derived from Cordyceps Militaris. Chinese Golden Grass is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine, as its enzymes appear to have a very favorable impact on boosting one’s immune system, lowering blood pressure, and combating gastrointestinal disorders.
In a recent interview with Nutraceuticals World, the CEO of PepsiCo was gushing about the use of Traditional Chinese Medicine products in all kinds of nutraceuticals, especially beverages in the near future.
Free Report From Goldman Small Cap Research
Nutrastar International, Inc.
2.25 -0.55 (-19.64%)
Intraday |
3 Month |
6 Month |
1 Year
Quotes delayed at least 20 mins.
With a 19% market share, Nutrastar has enjoyed stellar growth and leadership status based upon its patented cultivation and production technology. Nutrastar is the only company able to produce a Chinese Traditional Medicine product in a man-made environment on a commercial scale.
Goldman believes that the Company’s strong management, enviable profit margins, and a large cash position translate into continued success. Following a recent equity offering, Nutrastar has roughly $1.00 in net cash per share and is generating 50% net margins. With the world’s first energy drink made from Cordycepin introduced in 2Q10, the annual sales growth could approach 45% in 2010.
It is easy to see why Goldman Small Cap Research believes that Nutrastar is an incredibly undervalued stock. It is a pure play on the fast-growing nutraceutical market and also the all-important Chinese domestic market. In addition, with huge sales growth, high net margins and a large cash position, the risk profile is dramatically reduced at current levels. After all, the stock is trading around 3x net cash---not earnings-net cash, due to the fact that the Street has not gotten a hold of the story yet.
Following a very profitable 2009 in which Nutrastar earned $7.7M on $15.3M in revenue, Goldman projects $21.5 in sales and $0.62 EPS for 2010 and $28.5M in sales with $0.75 in EPS next year. By initially assigning a conservative 12x multiple on FY10E EPS, the stock could clearly reach the $7.00 price target in short order. The stock closed at $3.16 on Monday, which means that Goldman’s target is more than a double from here, and that is conservative. Goldman Small Cap rates Nutrastar a Speculative Buy.
Promising Numbers
Report projections
2010: $21.5 in sales with $0.62 EPS
2011: $28.5M in sales (www.goldmanresearch.com/images/reports/nuin8.9.10summary.pdf)
Great stuff...I got a starter position at 2.67 recently...thanks to Gary for finding another winner. $7 target is pretty conservative... china stocks are just starting to gain some traction, by Christmas many of them will have tripled or more imo.
I'm in over 100 of them for smaller stakes...simply trading the volatility and taking "free" stock as profit works so well... I love having a position in many of these...preferably "risk free" from swing trading. Simply buy oversold, and sell enough at "overbought" to have a free ride. The funny thing about these china plays is that "overbought" is still fundamentally undervalued!!
Goldman coverage - no, not that Goldman! But at least someone else is giving the company some exposure.
"Good morning! Today we are initiating coverage of a very exciting firm. Nutrastar (NUIN) is a pure play on the fast-growing nutraceutical market and the domestic market in China. Here are 5 reasons to buy the stock: The Company has 19% mkt share in the Chinese Golden Grass segment of Traditional Chinese Medicine, which has been touted by PepsiCo's CEO recently. Nutrastar just introduced a new product that will further increase its sales and mkt share penetration. The Company has huge profit margins; over 70% gross margin and 50% net margin. The stock is a total unknown and is trading 3x net cash per share! We predict the stock will go from $2.89 to $7.00. At that level it will only be trading 12x trailing tweleve months EPS. Veyr conservative for an absolute cash cow. Please read the summary (link attached below) and download the report. It is chock full of interesting information. Rob" Goldmanrob@goldmanresearch.com
http://www.goldmanresearch.com/images/reports/nuin8.9.10summary.pdf
Nutrastar International, Inc. Signs Product Purchase Agreement Valued at RMB 10 Million (US $1.47 Million)
Nutrastar International Inc. Common Stock (USOTC:NUIN)
Tuesday 27 July 2010
Nutrastar International, Inc. (OTC Bulletin Board: NUIN; "Nutrastar" or the "Company"), a leading nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris"), today announced that that it signed a one year product purchase agreement with Century Brighton Holdings Limited on June 18th, 2010, valued at approximately RMB 10 million (US $1.47 Million).
Under the agreement, Century Brighton Holdings will sell small packages of Golden Grass as an agent for Nutrastar International. The initial batch of goods, purchased by Century in July 2010, amounts to RMB 2 Million (US $0.3 Million). The products will be distributed by Century Brighton through its sales channels to private, high-end entertainment and leisure establishments in Hong Kong and Beijing.
Century Brighton was founded in Hong Kong in 2002 and mainly operates as the sales agent or distributor for high-end ginseng, tea and wine in China and Hong Kong. This new purchase agreement will increase Nutrastar's geographical footprints in the Hong Kong and Beijing market. Furthermore, the availability of Golden Grass in the high-end entertainment and leisure establishments will further promote the product's brand awareness among the middle to upper class consumers and further boost Nutrastar's image as a leading supplier of Golden Grass to the Chinese market.
Ms. Lianyun Han, Founder and Chief Executive Officer of Nutrastar commented, "We are very excited to add Century Brighton to our dedicated list of purchasing agents. We anticipate that through their vast network of distributors and customers, we will continue to expand our sales and geographical footprint as a leading supplier of Golden Grass to the Chinese marketplace."
About Nutrastar International, Inc.
Nutrastar International, Inc. is a China based nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris"), organic and specialty food products in China. The Company's primary product is dry engineered Chinese Golden Grass, which is one of the most highly regarded herbal nutrients in Chinese culture. The Company believes it is the largest manufacturer of engineered Chinese Golden Grass in China, ranked by volume, according to China Market Monitoring Center (CMMC), accounting for 19% market share in China. The Company is headquartered in Harbin, capital of Heilongjiang province, with 302 employees, 21 in R&D, and 132 in sales and marketing. The products of Nutrastar are sold throughout China via a distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com or e-mail: ir@nutrastarintl.com .
http://ih.advfn.com/p.php?pid=nmona&article=43755287&symbol=NUIN
Nutrastar Int. appoints new bilingual CFO
I had the pleasure of speaking with the new CFO, Robert Tick last week on Friday. He is experienced, and from our conversation I got the strong impression that he is committed to enhancing shareholder value. I've been investing in Chinese small caps since 1999 and frequently talk to management- particularly CFOs.. and I was as impressed by Robert as I've been with any CFO to be honest. This is a strong addition to the management team. My partner, Yicheng Tong will be visiting the company in a few weeks- and will most likely meet up with Robert Tick that time as well.
"Nutrastar International, Inc. Appoints Robert Tick as Chief Financial Officer"
http://finance.yahoo.com/news/Nutrastar-International-Inc-prnews-2891862140.html?x=0&.v=26
NUIN management and legal consel (Pillsbury Winthrup) was not contacted previously about any delinquency by FINRA according to what I've been told, however their consel is working on it now.
This has to do with forms that were required to be filed during the RM process from my understanding. From what little I know, it appears there was a document that was required that was not sent in, or wasn't filled out properly, and the company wasn't notified of this until now.
NUIN is now a pink sheet, as they can't even properly file SEC documents and have thus been demoted. This company is total junk and not worth investing 10 cents in unless of course you want to lose your 10 cents ........
"I don't have an opinion on NUIN, but I thought the report was very well done. It's obvious you have a problem with Gary and his group and don't really care about this company. You have been trashing this company for 2 weeks now and you decide to send IR an e-mail only to trash these guys some more."
I don't have an opinion on NUIN, but I thought the report was very well done.
It's obvious you have a problem with Gary and his group and don't really care about this company. You have been trashing this company for 2 weeks now and you decide to send IR an e-mail only to trash these guys some more.
Interesting- it works for me.
I suppose if others care to investigate further they'll find the email contact works for them also.
What a joke, as my copy of e-mail to IR bounced back .......
Undeliverable: Nutrastar is wasting its money .......?
6/30/10
To: xxxxxxx@hotmail.com
Delivery has failed to these recipients or distribution lists:
info@amcapventures.com
The recipient's e-mail address was not found in the recipient's e-mail system. Microsoft Exchange will not try to redeliver this message for you. Please check the e-mail address and try resending this message, or provide the following diagnostic text to your system administrator.
info@amcapventures.com
#550 5.1.1 RESOLVER.ADR.RecipNotFound; not found ##
From: xxxx xxxxxxx <xxxxxxx@hotmail.com>
To: <zhaoyudi@nutrastarintl.com>, <ir@nutrastarintl.com>,
<info@amcapventures.com>, <zhaoyudi@syxny.net>
Subject: Nutrastar is wasting its money .......
Date: Wed, 30 Jun 2010 06:49:12 -0500
--Forwarded Message Attachment--
From: xxxxxxx@hotmail.com
To: zhaoyudi@nutrastarintl.com; ir@nutrastarintl.com; info@amcapventures.com; zhaoyudi@syxny.net
Subject: Nutrastar is wasting its money .......
Date: Wed, 30 Jun 2010 06:49:12 -0500
Hi Yudi,
Your company recently hired American Capital Ventures as Nutrastar's IR firm, breaking away from HC International, one of the most respected IR firms on Wall Street. In my opinion, this was a horrible move and will simply result in a total waste of the company's money. In fact, American Capital Ventures recently spent $20K of Nutrastar's money on hiring China Growth Partners to write an article about Nutrastar and give an investment opinion ........
http://finance.yahoo.com/news/China-Growth-Partners-Inc-iw-1818935398.html?x=0&.v=1
Do you have any idea about who China Growth Partners is ? It's a brand new firm consisting of three guys with no IR experience whatsoever, three guys who are message board posters on IHUB, investorshub.com who thought they might have influence in getting some of their IHUB friends to buy your stock. Obviously it didn't work and was a miserable failure. In looking at the company's stock price, it's obvious that this $20K report did absolutely nothing and was a total waste of money. Do you honestly think that the report (link above) was worth paying $20K for ? I can tell you right now that I would have charged no more than $1K to do this kind of amateur report.
If I were you, I would simply focus on operating your business and stop throwing money away that is simply burning a hole in the company's pocket and hurting the bottom line. I can tell you from experience that both of the above firms will do absolutely NOTHING for the stock price of your company. Please concentrate on the growth of your business and put an end to this expensive nonsense.
Have a nice day.
xxxx xxxxxxx
Dude, I posted an e-mail I sent to the company and you replied with a post that contained thoughts about a poster. Please take time to read the T.O.S. rules and acquaint yourself with them.
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
203
|
Created
|
10/29/08
|
Type
|
Free
|
Moderators |
Nutrastar International Inc.
Ticker: NUIN.OB
Web site: http://www.syxny.net
Fiscal Year End: 12/31
Shares Outstanding: 14.3M
2009 Revenue: $15.3M USD
2009 Net Income: $7.7M USD
2009 EPS: .58
2009 Cash Flow from Operations: $9.3M USD
Research Report (June 2010) available here:
Forward statements by management:
"During 2010, Nutrastar plans to further increase the percentage of total revenue generated through sales of Chinese Golden Grass, both through increased sales of product processed and packaged for the consumer marketplace as well as sales of raw material to the pharmaceutical industry. The Company expects that further product awareness, widespread availability and increased health awareness among Chinese consumers will drive consumer adoption and sales for the Company's Golden Grass.
A major initiative of Nutrastar's future growth strategy is the introduction of new, value-added products targeting multiple downstream markets, including mass consumer, nutraceutical and pharmaceutical markets. After successfully introducing the small package consumer cordyceps products, the Company's growth plan during 2010 will include introducing a new branded specialty beverage product known as "Golden Grass Energy Drink". Commercialization of Golden Grass Energy Drink is scheduled for the second quarter of 2010, targeting affluent, professional, athletic and elderly consumers.
In support of its growth strategies, Nutrastar plans to increase annual production capacity from its current capacity of 55 tons to 65 tons by the end of 2010. Nutrastar operates the world's largest Chinese Golden Grass planting base, and employs patented technology in the cultivation and commercialization of Chinese Golden Grass. The Company also has cutting edge research and development capabilities that drives technology innovation.
"Given our leadership position in a growing market with high barriers to entry, supported by a well known and certified product brand, we are very optimistic about our growth prospects for 2010 and beyond," added Mr. Daniel Lee, CFO. "We anticipate incremental revenue and earnings growth of our higher margin Chinese Golden Grass products. We are very pleased with our progress to grow sales through downstream market applications and look forward to the successful launch of our specialty consumer beverage. In addition, we will be expanding into new pharmaceutical, nutraceutical and mass consumer markets which will bring the Company additional distribution channels, technologies and licensing opportunities, as we aim to become a leading nutraceutical company in China."
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |